Tetanus (Clostridium tetani)

Creative Diagnostics now offers high quality Tetanus (Clostridium tetani) antigens, antibodies and ELISA kits for research use.

Antigens to Tetanus (Clostridium tetani)

Tetanus antigen from various expression systems
Highly purified Tetanus Toxin
Tetanus toxoid is a useful carrier protein for haptens

Cat. No.	Product Name	Expression System	Nature
DAGA-115	Tetanus Toxoid	Purified	Native
DAG2636	Recombinant C. tetani TeNT Light Chain, His-tagged	E. coli	Recombinant

Antibodies to Tetanus (Clostridium tetani)

Species Reactivity: C. tetani
Conjugate: Unconjugated

Cat. No.	Product Name	Host	Application
DPAB31516	Anti-C. tetani Polyclonal antibody	Goat	ELISA, WB, IF, IP

Kits to Tetanus (Clostridium tetani)

Quantitative determination
Excellent precision and reproducibility
Highly sensitivity

Cat. No.	Product Name
DEIA1026	Human Tetanus Toxoid antibody ELISA Kit
DEIA2568	Tetanus Toxoid IgG ELISA
DEIA1794	Tetanus Toxin IgG ELISA Kit

Tetanus (Clostridium tetani)

Tetanus is a nervous system disease caused by a toxin (tetanospasmin) produced by Clostridium tetani.
Tetanus is divided into four clinical types: generalized, localized, cephalic, and neonatal.
C. tetani is an obligately anaerobic bacillus.
Tetanus produces two toxins: tetanospasmin (toxin) and tetanolysin.
It develops a terminal spore that is extremely stable in the environment, retaining the ability to germinate and cause disease indefinitely.

During growth, the bacilli possess abundant flagella and are sluggishly motile. Two toxins, tetanospasmin (commonly called tetanus toxin) and tetanolysin, are produced during this phase. Tetanospasmin is encoded on a plasmid that is present in all toxigenic strains. Tetanolysin is of uncertain importance in the pathogenesis of tetanus. Mature organisms lose their flagella, develop a terminal spore, and begin to resemble a squash racquet.

Tetanus (Clostridium tetani)

Tetanospasmin is synthesized as a single 151-kDa chain that is cleaved extracellularly by a bacterial protease into a 100-kDa heavy chain and a 50-kDa light chain (fragment A), which remain connected by a disulfide bridge. The heavy chain can be further divided into fragments B and C by pepsin. The heavy chain appears to mediate binding to cell surface receptors and transport proteins, whereas the light chain produces the presynaptic inhibition of transmitter release that produces clinical tetanus.